JENNIFER QUIGLEY: Open Payments
NPI 1689430381 · FLAGSTAFF, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$742 in 24 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $378 · 2025 $742
Food & beverage: $742
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 3 | $199 |
| ABBVIE INC. | 4 | $82 |
| Ipsen Biopharmaceuticals, Inc | 3 | $81 |
| Merit Medical Systems Inc | 1 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $61 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $55 |
| GENZYME CORPORATION | 2 | $53 |
| Aimmune Therapeutics, Inc. | 2 | $42 |
| PFIZER INC. | 1 | $29 |
| Intercept Pharmaceuticals, Inc. | 1 | $29 |
Products named: REZDIFFRA, IQIRVO, DUPIXENT, ESOPHYX, SKYRIZI, ENTYVIO, XIFAXAN, ZENPEP.
Industry payments across AZ — which companies pay providers there.
